Chee Tao Chang

664 total citations
42 papers, 317 citations indexed

About

Chee Tao Chang is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Health. According to data from OpenAlex, Chee Tao Chang has authored 42 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Geriatrics and Gerontology, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Health. Recurrent topics in Chee Tao Chang's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Antibiotic Use and Resistance (5 papers) and Vaccine Coverage and Hesitancy (4 papers). Chee Tao Chang is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Antibiotic Use and Resistance (5 papers) and Vaccine Coverage and Hesitancy (4 papers). Chee Tao Chang collaborates with scholars based in Malaysia, United States and Kuwait. Chee Tao Chang's co-authors include Lynn Spivak, Dennis Davidson, Paul H. Lipkin, Richard Straube, R Philip, Xin-Jie Lim, Asrul Akmal Shafie, Wah Yun Low, Huan‐Keat Chan and Ming Lee and has published in prestigious journals such as PLoS ONE, The Journal of Pediatrics and International Journal of Environmental Research and Public Health.

In The Last Decade

Chee Tao Chang

37 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chee Tao Chang Malaysia 9 96 64 52 50 45 42 317
Samuel K. Peasah United States 11 35 0.4× 206 3.2× 78 1.5× 9 0.2× 42 0.9× 38 530
Hala Al-Obaidi United Arab Emirates 10 16 0.2× 62 1.0× 34 0.7× 48 1.0× 29 0.6× 22 279
Elizabeth M. Viglianti United States 13 57 0.6× 119 1.9× 38 0.7× 7 0.1× 27 0.6× 52 547
Eilidh Fletcher United Kingdom 11 35 0.4× 50 0.8× 69 1.3× 8 0.2× 8 0.2× 25 301
Reema Syed United States 8 66 0.7× 106 1.7× 28 0.5× 277 5.5× 145 3.2× 14 527
Brita M. de Jong Netherlands 8 133 1.4× 81 1.3× 11 0.2× 5 0.1× 26 0.6× 11 303
Dorota Juszczyk United Kingdom 8 76 0.8× 133 2.1× 8 0.2× 153 3.1× 12 0.3× 18 544
Shakti Shrestha Nepal 13 44 0.5× 72 1.1× 6 0.1× 33 0.7× 138 3.1× 68 429
Jón Steinar Jónsson Iceland 9 99 1.0× 64 1.0× 5 0.1× 23 0.5× 14 0.3× 21 284
Sarah Seelye United States 10 43 0.4× 100 1.6× 21 0.4× 26 0.5× 6 0.1× 31 263

Countries citing papers authored by Chee Tao Chang

Since Specialization
Citations

This map shows the geographic impact of Chee Tao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee Tao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee Tao Chang more than expected).

Fields of papers citing papers by Chee Tao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee Tao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee Tao Chang. The network helps show where Chee Tao Chang may publish in the future.

Co-authorship network of co-authors of Chee Tao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chee Tao Chang. A scholar is included among the top collaborators of Chee Tao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee Tao Chang. Chee Tao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Chee Tao, Huan‐Keat Chan, Yoon Yeo, et al.. (2024). Comparing Beers, STOPP and MALPIP criteria in detecting potentially inappropriate medications, clinical outcomes, and cost impacts among older Malaysians: a cohort study. Journal of Pharmaceutical Policy and Practice. 17(1). 2436896–2436896.
2.
Chang, Chee Tao, Huan‐Keat Chan, Muhammad Radzi Abu Hassan, et al.. (2024). Factors influencing healthcare providers’ behaviours in deprescribing: a cross-sectional study. Journal of Pharmaceutical Policy and Practice. 17(1). 2399727–2399727. 2 indexed citations
3.
Chang, Chee Tao, et al.. (2023). Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review. Research in Social and Administrative Pharmacy. 19(8). 1146–1156.
4.
5.
Chang, Chee Tao, et al.. (2023). Development and validation of patient diabetes knowledge questionnaire (PDKQ). Journal of Pharmaceutical Policy and Practice. 16(1). 121–121. 2 indexed citations
6.
7.
Chang, Chee Tao, et al.. (2023). Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitals. Journal of Pharmaceutical Policy and Practice. 16(1). 2–2. 8 indexed citations
8.
Lim, Xin-Jie, et al.. (2023). Perceived unmet needs of an age-friendly environment: A qualitative exploration of older adults’ perspectives in a Malaysian city. PLoS ONE. 18(6). e0286638–e0286638. 2 indexed citations
9.
Chang, Chee Tao, et al.. (2022). Monkeypox outbreak: Preventing another episode of stigmatisation. Tropical Medicine & International Health. 27(9). 754–757. 12 indexed citations
10.
Chang, Chee Tao, et al.. (2022). Health system preparedness in infectious diseases: perspective of Malaysia, a middle-income country, in the face of monkeypox outbreaks. Tropical Medicine and Health. 50(1). 87–87. 2 indexed citations
11.
Chang, Chee Tao, et al.. (2022). Perceived Gap of Age-Friendliness among Community-Dwelling Older Adults: Findings from Malaysia, a Middle-Income Country. International Journal of Environmental Research and Public Health. 19(12). 7171–7171. 3 indexed citations
12.
Chang, Chee Tao, et al.. (2022). Abstinence Rate, Adverse Events and Withdrawal Symptoms after Varenicline Use and Predicting Factors of Smoking Abstinence: A Multicentre Single-State Study in Malaysia. International Journal of Environmental Research and Public Health. 19(13). 7757–7757.
13.
14.
Lim, Xin-Jie, et al.. (2021). Experiences of social stigma among patients tested positive for COVID-19 and their family members: a qualitative study. BMC Public Health. 21(1). 1623–1623. 42 indexed citations
15.
Chang, Chee Tao, et al.. (2021). Satisfaction among patients and caregivers receiving value-added services during the COVID-19 pandemic outbreak in a tertiary hospital in the Perak state of Malaysia. Journal of Pharmaceutical Health Services Research. 12(4). 477–484. 2 indexed citations
16.
Chang, Chee Tao, et al.. (2020). Drive‐through transcutaneous bilirubin screening for neonatal jaundice: A safe and efficient system during the COVID‐19 pandemic. Journal of Paediatrics and Child Health. 57(1). 12–14. 4 indexed citations
17.
Chang, Chee Tao, et al.. (2020). Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital. International Journal of Clinical Pharmacy. 43(1). 46–54. 4 indexed citations
18.
19.
Chang, Chee Tao, et al.. (2019). Perceived motivators, training supports and challenges to career advancement among pharmacists in the Malaysian public healthcare system. International Journal of Pharmacy Practice. 27(6). 555–564. 5 indexed citations
20.
Chang, Chee Tao, et al.. (2018). Adherence and challenges in administering eye medications among glaucoma patients in a Malaysian public tertiary care centre. Journal of Pharmaceutical Health Services Research. 9(4). 361–365. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel K. Peasah Breakdown of academic impact, for papers by Hala Al-Obaidi Breakdown of academic impact, for papers by Elizabeth M. Viglianti Breakdown of academic impact, for papers by Eilidh Fletcher Breakdown of academic impact, for papers by Reema Syed Breakdown of academic impact, for papers by Brita M. de Jong Breakdown of academic impact, for papers by Dorota Juszczyk Breakdown of academic impact, for papers by Shakti Shrestha Breakdown of academic impact, for papers by Jón Steinar Jónsson Breakdown of academic impact, for papers by Sarah Seelye
Rankless by CCL
2026